Skip to main content

Medtronic Value Stock - Dividend - Research Selection


ISIN: IE00BTN1Y115 , WKN: A14M2J

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions.


The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software.


The company was founded in 1949 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Medtronic : Covidien Japan and HOGY Medical conclude a service agreement to commence cooperation on the sale of SuReFInD®

TOKYO - May 24, 2024 - Covidien Japan, Inc., , one of three Medtronic subsidiaries in Japan, concluded a service agreement on May 1 with HOGY Medical Co., Ltd. to cooperate on the sale of SuReFInD®,...

News Highlights : Top Company News of the Day - Thursday at 9 PM ET

Intuit warns of fewer TurboTax users who file for free. It says it's not interested in them anyway. Intuit Inc., the tech company behind TurboTax filing software and the personal-finance site...

Sector Update: Health Care Stocks Retreat Late Afternoon

Sector Update: Health Care Stocks Retreat Late Afternoon

Medtronic (MDT) Q4 2024 Earnings Call Transcript

MDT earnings call for the period ending March 31, 2024.

Medtronic's Q4 Earnings: Medical Device Giant Clocks Strong Sales From Neurology Devices, Hikes Dividend

Medtronic Plc (NYSE:MDT) reported fourth-quarter 2024 sales of $8.59 billion, beating the consensus of $8.44 billion. Revenue increased 0.5%, as reported, and 5.4% organic. The company’s organic revenue results reflect broad-based growth across the company, with mid-single-digit or higher organic revenue growth in all four segments. The medical device maker reported adjusted EPS of $1.46, beating the consensus of $1.45. Related: Medtronic’s Latest Generation Of Transcatheter Aortic Valve Replace

Why Medtronic Stock Slumped Today

A 27x earnings valuation and single-digit growth rate means Medtronic stock is probably going down.

Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down

Growth across Cranial & Spinal Technologies, Diabetes, Cardiac Pacing and Surgical businesses contributes to Medtronic's (MDT) Q4 revenues.

Stocks to Watch Thursday: Nvidia, Snowflake, Live Nation

**↗️** **Nvidia (NVDA)**: The chip maker's shares rose 10% in early trading after it reported a record quarter and announced a 10-for-1 stock split, effective in June. **↗️** **News Corp (NWSA)**: The Wall Street Journal's owner struck a licensing pact with OpenAI valued at over $250 million.

Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Medtronic Guides for Annual Growth in Fiscal 2025 as Fourth-Quarter Results Top Views

Medtronic Guides for Annual Growth in Fiscal 2025 as Fourth-Quarter Results Top Views